Q4 2024 Earnings Call Transcript February 3, 2025 Operator: Good morning, and welcome to the IDEXX Laboratories’ Fourth ...

IDEXX Laboratories, Inc. (NASDAQ:IDXX), a leader in veterinary diagnostics and software, has been navigating a complex market landscape characterized by fluctuating veterinary visit trends and ...

IDEXX Laboratories exceeded fourth-quarter profit and revenue estimates on sales of its animal testing products and price ...

Idexx Laboratories exceeded earnings expectations for Q4 2024, buoyed by robust performance in its key diagnostic segments.

IDEXX Laboratories, Inc.’s IDXX share price has surged by 11.13%, which has investors questioning if this is right time to ...

IDEXX Laboratories ( IDXX) was the best-performing stock in the S&P 500 after the provider of veterinary healthcare products ...

IDEXX Laboratories, Inc. ( NASDAQ: IDXX) Q4 2024 Earnings Conference Call February 3, 2025 8:30 AM ET Brian McKeon - Chief Financial Officer Andrew Emerson - Senior Vice President, Corporate & ...

周一，Stifel分析师调整了IDEXX ...

IDEXX Laboratories beat Wall Street estimates for fourth-quarter revenue and profit on Monday, helped by strong demand for its veterinary diagnostic services despite persistent weakness in visits to ...

周一，BTIG分析师Mark Massaro宣布将IDEXX Laboratories (NASDAQ: IDXX )的目标股价从500美元上调至530美元，同时维持对该股票的买入评级。此次调整是在IDEXX第四季度业绩超出收入和盈利预期后做出的。目前，该公司市值为385亿美元，股价为469.04美元，InvestingPro分析显示该股票的交易价格高于其公允价值。

Idexx forecast revenue between $4.06 billion and $4.17 billion in 2025, in line with analysts' estimates of $4.14 billion. The company also guided for earnings per share in the range of $11.74 and $12 ...

Stock indexes closed lower on Monday with tech stocks taking a hit, though partly recovering as President Trump delayed ...